by McDermott + Bull | Feb 20, 2025 | Ken Dropiewski, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Ken Dropiewski Placement Announcement, Kevin Kim, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Michael Selberis as Chief Technology Officer at ClinNEXUS. Michael will lead the development and execution of ClinNEXUS’s technology strategy, overseeing all aspects of technological direction to ensure alignment with the...
by McDermott + Bull | Jan 20, 2025 | Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement
McDermott + Bull has successfully placed Courtney Walton as Vice President of Quality & Regulatory at Natus Neuro. Courtney will be reporting directly to the Chief Executive Officer and will lead the company’s efforts to achieve and maintain excellence in quality...
by McDermott + Bull | Nov 27, 2024 | Ken Dropiewski, Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski Article
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
by McDermott + Bull | Nov 20, 2024 | Ken Dropiewski, Investor Insights, Video
McDermott + Bull Partner Ken Dropiewski sits down with Lightstone Ventures General Partner Mike Carusi to explore essential topics for CEOs and investors. Mike provides an inside look at Lightstone Ventures’ focus areas and shares his perspective on current...
by McDermott + Bull | Nov 7, 2024 | Ken Dropiewski, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
by McDermott + Bull | Sep 18, 2024 | Chris Bull, Anne Terry, Chris Bull Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Hussain Rangwala as Chief Technology Officer at Inari Medical. Reporting to the CEO, Hussain will drive the development and execution of innovative R&D strategies, including fostering a culture of innovation, ensuring...
